Abstract
Dietary protein restriction has been demonstrated to improve metabolic health under various conditions. However, the relevance of ageing and age-related decline in metabolic flexibility on the effects of dietary protein restriction has not been addressed. Therefore, we investigated the effect of short-term dietary protein restriction on metabolic health in young and aged mice. Young adult (3 months old) and aged (18 months old) C57Bl/6J mice were subjected to a 3-month dietary protein restriction. Outcome parameters included fibroblast growth factor 21 (FGF21) levels, muscle strength, glucose tolerance, energy expenditure (EE) and transcriptomics of brown and white adipose tissue (WAT). Here, we report that a low-protein diet had beneficial effects in aged mice by reducing some aspects of age-related metabolic decline. These effects were characterized by increased plasma levels of FGF21, browning of subcutaneous WAT, increased body temperature and EE, while no changes were observed in glucose homeostasis and insulin sensitivity. Moreover, the low-protein diet used in this study was well-tolerated in aged mice indicated by the absence of adverse effects on body weight, locomotor activity and muscle performance. In conclusion, our study demonstrates that a short-term reduction in dietary protein intake can impact age-related metabolic health alongside increased FGF21 signalling, without negatively affecting muscle function. These findings highlight the potential of protein restriction as a strategy to induce EE and browning of WAT in aged individuals.
Original language | English |
---|---|
Pages (from-to) | 2257-2277 |
Number of pages | 21 |
Journal | FEBS Journal |
Volume | 288 |
Issue number | 7 |
Early online date | 22 Oct 2020 |
DOIs | |
Publication status | Published - Apr 2021 |
Bibliographical note
Funding Information:We thank Martijn Koehorst, Pim de Blaauw, Angelika Jurdzinski and Rick Havinga for excellent technical assistance, and Dicky Struik, Henkjan Verkade and Rebecca Heiner‐Fokkema for valuable feedback on the manuscript. This study was supported by an infrastructure grant from The Netherlands Organisation of Scientific Research (NWO): the Mouse Clinic for Cancer and Ageing (MCCA) and grants from The Netherlands Organization for Scientific Research (VICI grant 016.176.640 to JWJ), The Netherlands Organization for Scientific Research and the Dutch Diabetes Research Foundation (Diabetes II Breakthrough Project 459001005 to JKK), European Foundation for the Study of Diabetes (award supported by EFSD/Novo Nordisk to JWJ), a UMCG‐GSMS PhD fellowship to MAVL and the De Cock Stichting. The EE ANCOVA analysis done for this work was provided by the NIDDK Mouse Metabolic Phenotyping Centers (MMPC, www.mmpc.org ) using their EE Analysis page ( http://www.mmpc.org/shared/regression.aspx ) and supported by grants DK076169 and DK115255.
Publisher Copyright:
© 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
Funding
We thank Martijn Koehorst, Pim de Blaauw, Angelika Jurdzinski and Rick Havinga for excellent technical assistance, and Dicky Struik, Henkjan Verkade and Rebecca Heiner‐Fokkema for valuable feedback on the manuscript. This study was supported by an infrastructure grant from The Netherlands Organisation of Scientific Research (NWO): the Mouse Clinic for Cancer and Ageing (MCCA) and grants from The Netherlands Organization for Scientific Research (VICI grant 016.176.640 to JWJ), The Netherlands Organization for Scientific Research and the Dutch Diabetes Research Foundation (Diabetes II Breakthrough Project 459001005 to JKK), European Foundation for the Study of Diabetes (award supported by EFSD/Novo Nordisk to JWJ), a UMCG‐GSMS PhD fellowship to MAVL and the De Cock Stichting. The EE ANCOVA analysis done for this work was provided by the NIDDK Mouse Metabolic Phenotyping Centers (MMPC, www.mmpc.org ) using their EE Analysis page ( http://www.mmpc.org/shared/regression.aspx ) and supported by grants DK076169 and DK115255.
Funders | Funder number |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases | DK076169, U24DK115255 |
European Foundation for the Study of Diabetes | |
Diabetes Fonds | 459001005 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 016.176.640 |
Novo Nordisk |
Keywords
- browning of white adipose tissue
- dietary protein restriction
- energy metabolism
- FGF21 signalling
- thermogenesis